Lifeboat Foundation

Are quantum events required for consciousness in a very special sense, far beyond the general sense that quantum events are part of all physical systems? What would it take for quantum events, on such a micro-scale, to be relevant for brain function, which operates at the much higher level of neurons and brain circuits? What would it mean?

Free access to Closer to Truth’s library of 5,000 videos: http://bit.ly/376lkKN

Continue reading “Donald Hoffman — Quantum Physics of Consciousness” »

This article is an installment of Future Explored, a weekly guide to world-changing technology. You can get stories like this one straight to your inbox every Thursday morning by subscribing here.

The Australian military is funding a project to grow intelligent “mini-brains” in petri dishes. The goal is to use these “DishBrains” to design better AIs — and, eventually, even combine the two, creating AIs merged with processing features of human brain cells.

Continue reading “Australian military is funding a computer chip merged with human brain cells” »

DEAR MAYO CLINIC: I’ve heard about several people who have experienced sudden cardiac arrest. What is cardiac arrest? And how is it different from a heart attack? What do you do for someone who has this condition?

ANSWER: Cardiac arrest, or sudden cardiac arrest as it is more formally known, is a medical emergency. Think of it as a problem with the heart’s electrical activity. This synchronized electrical activity allows the heart to fill and pump blood normally. Sudden cardiac arrest can happen unexpectedly and quickly, and the heart stops working. It’s not the same as a heart attack, but it is just as critical that treatment occurs rapidly.

Cardiac arrest is when the heart cannot fulfill its duties, such as pumping oxygenated blood around the body to reach critical areas such as the brain and the rest of the body. It is sometimes called “sudden” because it seems to happen without warning. A person suddenly loses all heart activity, stops breathing and becomes unconscious. Without immediate treatment, sudden cardiac arrest can lead to death.

Researchers at Uppsala university have developed a new method to find mutations in brain tumors in children. They also showed that the mutations change how cancer cells respond to a cancer drug. These findings could lead to better diagnostics and more individualized treatment of children with brain tumors. The study is published in the journal Proceedings of the National Academy of Sciences.

Medulloblastoma is the most common malignant brain tumor in children. It usually develops in the cerebellum and although modern treatment has improved the prognosis so that more than 70% of patients now live more than five years, not all patients can be cured. The aggressive cancer treatment also causes severe side effects such as balance problems and impaired learning abilities in cancer survivors.

Numerous studies have explored the less than 2% of human DNA that gives rise to proteins, and much less is known about the rest of the genome. In a cancer, such as medulloblastoma, 98% of the mutations thus occur in the less studied part of the genome. There could be thousands of mutations, and it is difficult to separate the ones driving the cancer from those without importance.

An important objective of medical research is to identify the underlying molecular mechanisms of human brain health and diseases.

This objective has been predominantly achieved through observational studies of gene expression in human brain tissues obtained from post-mortem brain donors for their analysis. Importantly, many of these studies are based on the assumption that gene expression in the post-mortem human brain is an exact representation of gene expression in the living human brain.

A recent study published on the medRxiv preprint server challenges this assumption by comparing human prefrontal cortex gene expression between living and post-mortem samples.

A recent study posted to the medRxiv preprint server investigates the association between the circulating proteome and brain health.

Study: The circulating proteome and brain health: Mendelian randomisation and cross-sectional analyses. Image Credit: Abduramanova Elena / Shutterstock.com.

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

A new robotic headgear allows mice to move freely while being attached to heavy and cumbersome brain-recording machinery, allowing scientists to track their brain activity in motion, according to a new report by Spectrum published on Thursday. The development could have major implications in neuropathy and other sciences of the brain.

Under normal circumstances, researchers analyze brain activity in an awake mouse by fixing the animal’s head in a stiff unmovable position beneath a microscope. This however severely limits the mouse’s range of motion and therefore does not produce accurate results.

As Ted Abel, chair of neuroscience and pharmacology at the University of Iowa in Iowa City, who was not involved in the study, explained to Spectrum, this approach is not conducive to usable outcomes.

Still a big maybe but it gives them other ideas/possibilities. Hopefully they succeed soon! My mother has glaucoma. It’ll probably be decades before this cure happens though. Unless it can be accelerated which is predicted by Ray Kurzweil in his book The Singularity is Near. I think other futurists have said similar things though I’m not familiar with all of them, I saw a talk by one for NASA.

In efforts to tackle the leading cause of blindness in developed countries, researchers have recruited nanotechnology to help regrow retinal cells.

Macular degeneration is a form of central vision loss, which has massive social, mobility, and mental consequences. It impacts hundreds of millions of people globally and is increasing in prevalence.

Continue reading “Scientists Regrow Retinal Cells in The Lab Using Nanotechnology” »

Dopamine is a type of neurotransmitter that can provide an intense feeling of reward. It has been a long-standing assumption that most, if not all, dopamine neurons solely respond to rewards or reward-predicting cues. However, a study in mice led by researchers at Northwestern University reveals dopamine may also control movements. The researchers uncovered that one genetic subtype fires when the body moves and that these neurons do not respond to rewards at all.

The findings are published in Nature Neuroscience in an article titled, “Unique functional responses differentially map onto genetic subtypes of dopamine neurons,” and shed new light on the brain which may lead to new research on Parkinson’s disease, which is characterized by the loss of dopamine neurons yet affects the motor system.

“Dopamine neurons are characterized by their response to unexpected rewards, but they also fire during movement and aversive stimuli,” the researchers wrote. “Dopamine neuron diversity has been observed based on molecular expression profiles; however, whether different functions map onto such genetic subtypes remains unclear. In this study, we established that three genetic dopamine subtypes within the substantia nigra pars compacta, characterized by the expression of Slc17a6 (Vglut2), Calb1, and Anxa1, each have a unique set of responses to rewards, aversive stimuli, and accelerations and decelerations, and these signaling patterns are highly correlated between somas and axons within subtypes.”